Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriersLeonardo Delello Di Filippo, Marlus Chorilli, Juliana H. Azambuja et al.|European Journal of Pharmaceutics and Biopharmaceutics|2021Cited by 58
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progressionLeonardo Delello Di Filippo, Marlus Chorilli, Jonatas Lobato Duarte et al.|International Journal of Pharmaceutics|2022Cited by 48
Characterization and comparison of human and mouse milk cellsRose Doerfler, Kathryn A. Whitehead, Saigopalakrishna S. Yerneni et al.|PLoS ONE|2024Cited by 9
DDEL-01. ENGINEERING MRNA THERAPIES FOR BRAIN TUMORSSaigopalakrishna S. Yerneni, Kathryn A. Whitehead, Daria Strelkova-Petersen et al.|Neuro-Oncology|2024Cited by 0